A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development
Identifieur interne : 002145 ( Main/Exploration ); précédent : 002144; suivant : 002146A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development
Auteurs : A. Casartelli [Italie] ; M. Bonato [Italie] ; P. Cristofori [Italie] ; F. Crivellente [Italie] ; G. Dal Negro [Italie] ; I. Masotto [Italie] ; C. Mutinelli [Italie] ; K. Valko [Royaume-Uni] ; V. Bonfante [Italie]Source :
- Cell Biology and Toxicology [ 0742-2091 ] ; 2003-06-01.
English descriptors
- KwdEn :
Abstract
Abstract: Phospholipidosis is a term commonly used to indicate a phospholipid storage disorder; in affected cells, phospholipids accumulate in lysosomes that acquire a multilamellar morphological appearance. Cationic amphiphilic drugs (CADs) are suggested to induce phospholipidosis by direct interaction of xenobiotics with intracellular phospholipids or by the action of xenobiotics on the synthesis and metabolism of phospholipids. To date, electron microscopy (EM) represents the most reliable and the preferred method for the demonstration of phospholipidotic cell damage. Nevertheless, EM has a low throughput, it is expensive, and it is not suitable for screening purposes. We discuss here the assessment of the the phospholipidogenic potential of drugs using a cell culture-based model. In this test, intracellular phospholipids of treated U-937 cells (a human monocyte-derived cell line) were measured using the fluorescent probe Nile red. Eleven CADs reported to induce phospholipidosisin vivo and eight nonphospholipidogenic drugs were tested. Results obtained with the U-937 model confirmed the phospholipidogenic potential of drugs tested as described in the literature. Results have also been correlated with data obtained with a physical-chemical model (chromatographic hydrophobicity index measurement). Good correlation was obtained, confirming that the physical-chemical properties of CADs play a crucial role in the development of phospholipidosis. This work demonstrates that the U-937 model is a rapid and sensitive method for the determination of phospholipidosis-mediated cell damage. The specificity and the predictive potency observed make this method suitable for screening purposes in pharmaceutical development.
Url:
DOI: 10.1023/A:1024778329320
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C33
- to stream Istex, to step Curation: 000C33
- to stream Istex, to step Checkpoint: 000F81
- to stream Main, to step Merge: 002164
- to stream Main, to step Curation: 002145
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development</title><author><name sortKey="Casartelli, A" sort="Casartelli, A" uniqKey="Casartelli A" first="A." last="Casartelli">A. Casartelli</name></author><author><name sortKey="Bonato, M" sort="Bonato, M" uniqKey="Bonato M" first="M." last="Bonato">M. Bonato</name></author><author><name sortKey="Cristofori, P" sort="Cristofori, P" uniqKey="Cristofori P" first="P." last="Cristofori">P. Cristofori</name></author><author><name sortKey="Crivellente, F" sort="Crivellente, F" uniqKey="Crivellente F" first="F." last="Crivellente">F. Crivellente</name></author><author><name sortKey="Dal Negro, G" sort="Dal Negro, G" uniqKey="Dal Negro G" first="G." last="Dal Negro">G. Dal Negro</name></author><author><name sortKey="Masotto, I" sort="Masotto, I" uniqKey="Masotto I" first="I." last="Masotto">I. Masotto</name></author><author><name sortKey="Mutinelli, C" sort="Mutinelli, C" uniqKey="Mutinelli C" first="C." last="Mutinelli">C. Mutinelli</name></author><author><name sortKey="Valko, K" sort="Valko, K" uniqKey="Valko K" first="K." last="Valko">K. Valko</name></author><author><name sortKey="Bonfante, V" sort="Bonfante, V" uniqKey="Bonfante V" first="V." last="Bonfante">V. Bonfante</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4CF589E2F7611C9143A7AC69E40E3D469FAC3FF6</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1023/A:1024778329320</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-BMVS1DRB-B/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000C33</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C33</idno><idno type="wicri:Area/Istex/Curation">000C33</idno><idno type="wicri:Area/Istex/Checkpoint">000F81</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F81</idno><idno type="wicri:doubleKey">0742-2091:2003:Casartelli A:a:cell:based</idno><idno type="wicri:Area/Main/Merge">002164</idno><idno type="wicri:Area/Main/Curation">002145</idno><idno type="wicri:Area/Main/Exploration">002145</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development</title><author><name sortKey="Casartelli, A" sort="Casartelli, A" uniqKey="Casartelli A" first="A." last="Casartelli">A. Casartelli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Safety Assessment Department, GlaxoSmithKline Research Centre, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author><author><name sortKey="Bonato, M" sort="Bonato, M" uniqKey="Bonato M" first="M." last="Bonato">M. Bonato</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Safety Assessment Department, GlaxoSmithKline Research Centre, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author><author><name sortKey="Cristofori, P" sort="Cristofori, P" uniqKey="Cristofori P" first="P." last="Cristofori">P. Cristofori</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Safety Assessment Department, GlaxoSmithKline Research Centre, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author><author><name sortKey="Crivellente, F" sort="Crivellente, F" uniqKey="Crivellente F" first="F." last="Crivellente">F. Crivellente</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Safety Assessment Department, GlaxoSmithKline Research Centre, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author><author><name sortKey="Dal Negro, G" sort="Dal Negro, G" uniqKey="Dal Negro G" first="G." last="Dal Negro">G. Dal Negro</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Safety Assessment Department, GlaxoSmithKline Research Centre, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author><author><name sortKey="Masotto, I" sort="Masotto, I" uniqKey="Masotto I" first="I." last="Masotto">I. Masotto</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Safety Assessment Department, GlaxoSmithKline Research Centre, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author><author><name sortKey="Mutinelli, C" sort="Mutinelli, C" uniqKey="Mutinelli C" first="C." last="Mutinelli">C. Mutinelli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Facoltá di Medicina e Chirurgia, University of Verona</wicri:regionArea><wicri:noRegion>University of Verona</wicri:noRegion></affiliation></author><author><name sortKey="Valko, K" sort="Valko, K" uniqKey="Valko K" first="K." last="Valko">K. Valko</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Analytical Sciences Stevenage Department, Glaxo Medicines R&D Centre, Stevenage</wicri:regionArea><wicri:noRegion>Stevenage</wicri:noRegion></affiliation></author><author><name sortKey="Bonfante, V" sort="Bonfante, V" uniqKey="Bonfante V" first="V." last="Bonfante">V. Bonfante</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Safety Assessment Department, GlaxoSmithKline Research Centre, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Cell Biology and Toxicology</title><title level="j" type="abbrev">Cell Biol Toxicol</title><idno type="ISSN">0742-2091</idno><idno type="eISSN">1573-6822</idno><imprint><publisher>Kluwer Academic Publishers</publisher><pubPlace>Dordrecht</pubPlace><date type="published" when="2003-06-01">2003-06-01</date><biblScope unit="volume">19</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="161">161</biblScope><biblScope unit="page" to="176">176</biblScope></imprint><idno type="ISSN">0742-2091</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0742-2091</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>cationic amphiphilic drugs</term><term>chromatographic hydrophobicity index</term><term>flow cytometry</term><term>fluorescent probe</term><term>monocytes</term><term>phospholipidosis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Phospholipidosis is a term commonly used to indicate a phospholipid storage disorder; in affected cells, phospholipids accumulate in lysosomes that acquire a multilamellar morphological appearance. Cationic amphiphilic drugs (CADs) are suggested to induce phospholipidosis by direct interaction of xenobiotics with intracellular phospholipids or by the action of xenobiotics on the synthesis and metabolism of phospholipids. To date, electron microscopy (EM) represents the most reliable and the preferred method for the demonstration of phospholipidotic cell damage. Nevertheless, EM has a low throughput, it is expensive, and it is not suitable for screening purposes. We discuss here the assessment of the the phospholipidogenic potential of drugs using a cell culture-based model. In this test, intracellular phospholipids of treated U-937 cells (a human monocyte-derived cell line) were measured using the fluorescent probe Nile red. Eleven CADs reported to induce phospholipidosisin vivo and eight nonphospholipidogenic drugs were tested. Results obtained with the U-937 model confirmed the phospholipidogenic potential of drugs tested as described in the literature. Results have also been correlated with data obtained with a physical-chemical model (chromatographic hydrophobicity index measurement). Good correlation was obtained, confirming that the physical-chemical properties of CADs play a crucial role in the development of phospholipidosis. This work demonstrates that the U-937 model is a rapid and sensitive method for the determination of phospholipidosis-mediated cell damage. The specificity and the predictive potency observed make this method suitable for screening purposes in pharmaceutical development.</div></front></TEI><affiliations><list><country><li>Italie</li><li>Royaume-Uni</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Casartelli, A" sort="Casartelli, A" uniqKey="Casartelli A" first="A." last="Casartelli">A. Casartelli</name></noRegion><name sortKey="Bonato, M" sort="Bonato, M" uniqKey="Bonato M" first="M." last="Bonato">M. Bonato</name><name sortKey="Bonfante, V" sort="Bonfante, V" uniqKey="Bonfante V" first="V." last="Bonfante">V. Bonfante</name><name sortKey="Cristofori, P" sort="Cristofori, P" uniqKey="Cristofori P" first="P." last="Cristofori">P. Cristofori</name><name sortKey="Crivellente, F" sort="Crivellente, F" uniqKey="Crivellente F" first="F." last="Crivellente">F. Crivellente</name><name sortKey="Dal Negro, G" sort="Dal Negro, G" uniqKey="Dal Negro G" first="G." last="Dal Negro">G. Dal Negro</name><name sortKey="Masotto, I" sort="Masotto, I" uniqKey="Masotto I" first="I." last="Masotto">I. Masotto</name><name sortKey="Mutinelli, C" sort="Mutinelli, C" uniqKey="Mutinelli C" first="C." last="Mutinelli">C. Mutinelli</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Valko, K" sort="Valko, K" uniqKey="Valko K" first="K." last="Valko">K. Valko</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002145 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002145 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4CF589E2F7611C9143A7AC69E40E3D469FAC3FF6
|texte= A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development
}}
| This area was generated with Dilib version V0.6.33. |  |